Clinical Trials Week
Susan Hasty, Publisher
Table of Contents . . . November 8th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Clinical Trials Week | Other Publications
Allergy Medicine - Azelastine appears effective for patients still symptomatic after fexofenadine
Alzheimer Disease - Biotech company announces results of Alzheimer study
Clinical Practice - Full participation minimizes parallelisms and gaps between research and care
Drug Development - Oral telbivudine generates virological response in chronic hepatitis B patients
Angioedema - Fast-track designation announced for DX-88
Arthritis - Laser tested for use in outpatient procedure to treat arthritis in spinal joints
Atrial Fibrillation - ACT 1 enrollment completed for atrial fibrillation study
Bacterial Conjunctivitis - Clinical sites activated for AzaSite trials in bacterial conjunctivitis
Blood Substitute - Committee recommends PolyHeme trial continue without modification
Breast Cancer - Enrollment of MammoSite patient registry completed
Breast Cancer - Pharmaceutical company gains FDA clearance for cancer drug Provecta
Breast Cancer - U.S. NIH study seeks 50,000 sisters of women with breast cancer
Business & Finance - Medical device company focusing on eye disorders secures interim financing
Business Update - Strategic relationship formed to expedite, enhance quality of clinical trials
Cancer Therapy - FK228 gets fast-track designation for cutaneous T cell lymphoma
Cancer Therapy - Toledo Clinic Inc., Detroit-based cancer institute announce alliance
Clinical Trial - Survey evaluates willingness to allow children to participate in clinical trials
Coronary Syndrome - Library will serve as a model for future substudy design
Cystic Fibrosis - Data presented on tobramycin powder for inhalation
Cystic Fibrosis - Positive phase II results reported for cystic fibrosis drug
Depression - Second pivotal phase III clinical trial of CORLUX begins
Depression - Super-selective antidepressant effective, fast acting, better tolerated
Diabetes - Discovery companies file IND for DPP IV inhibitor to treat type II diabetes
Drug Delivery - Update provided on OraDisc technology
Drug Development - Clinical trial for peptide-based diabetes drug with GLP-1 analogue initiated
Finance - Cancer vaccine maker reports loss of $0.54 per share
Gastroenterology - Pharmaceutical company announces positive results of Balsalazide study
Generalized Anxiety Disorder - New data suggest Cipralex is superior to Paxil for GAD
Heart Devices - CMS reimbursement for Novacor LVAS increased
Herpes - Investigational trial completed for treatment of herpes
Herpesvirus - DNA vaccine trial initiated for treatment of herpes simplex type 2
Infectious Disease - New phase II study of hepatitis treatment underway
Inflammation - Company reports successful multiple-dose phase I study of CTI-01
Influenza Vaccine - Pharma company developing new flu vaccine
Insulin - Two-year follow-up data released from Taxus IV clinical trial
Leukemia - Clofarabine data presented at hematology meeting
Lung Cancer - Hypofractionated chest radiotherapy effective in non-small-cell lung cancer
Macular Degeneration - Anecortave acetate clinical results announced
Medical Devices - European approval granted for new breast implant
Medical Devices - First U.S. patient enrolled in feasibility trial for heart attack laser device
Mergers & Acquisitions - Pharmaceutical company closes acquisition of Laxdale, Ltd.
Metastatic Melanoma - CR011 advances as potential treatment for metastatic melanoma
Multiple Sclerosis - Additional data reaffirm clinical benefits of Copaxone treatment
Multiple Sclerosis - MS patients on COPAXONE therapy for 10 years showed less disability progression
Multiple Sclerosis - Pharma company reports completion of animal model of multiple sclerosis
Myocardial Infarction - Data supports heart attack treatment device for reducing infarct size
Non-Hodgkin Lymphoma - Epratuzumab exerts antitumor activity in aggressive non-Hodgkin lymphoma
Nutrition - Trial: FRS enhances athletic performance
Oncology - FDA approves abbreviated drug application for carboplatin injection
Pancreatic Cancer - CoFactor granted U.S. orphan drug status by the FDA
Parvovirus - Roche LightCycler assay sensitive for quantitatation of parvovirus B19 DNA
Patents - U.S. patent issued for diagnostic product to detect cervical cancer
Personnel - Edward Penhoet, PhD, steps down from Macugen-maker board
Personnel - GCAN101 maker appoints CEO and CFO
Personnel - James A. Harper joins board of psych/neurological drug company
Personnel - Molecular pharmaceuticals appoints William Halter, George G.C. Parker to board
Pneumonic Plague - U.S. NIH allergy institute awards $50 million for recombinant protein vaccine
Prostate Cancer - Early prostate cancer is clinically responsive to conformal proton therapy
Prostate Cancer - Taxotere extends life of prostate cancer patients
Restenosis - Thirty-day safety data reported from Taxus V drug-eluting stent trial
Rhinosinusitis - Positive clinical efficacy data on FACTIVE presented at meeting
Sexual & Reproductive Health - Testosterone patch revs up sex life for women after menopause
Space Research - ESA looking for more European women to volunteer for WISE bed-rest study
Stroke - Pharma companies announced trials for ischemic stroke treatment will continue
Tuberculosis Prevention - New vaccine boosts antituberculosis immunity
Type 1 Diabetes - Clearance given to initiate clinical trial for treatment for type 1 diabetes
Type 1 Diabetes - Insulin pumps effective for children with diabetes
Type 2 Diabetes - First sale of nonfood natural bulk sweetener to pharmaceutical company announced
Vaccine Development - European patent awarded for nicotine addiction vaccine
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
